(0.79%) 5 086.50 points
(0.62%) 38 304 points
(0.94%) 17 602 points
(0.39%) $79.31
(2.33%) $1.977
(0.02%) $2 311.50
(-0.89%) $26.51
(0.81%) $962.60
(0.16%) $0.935
(0.36%) $11.07
(0.09%) $0.799
(-1.24%) $92.10
Quarter results today
(bmo 2024-05-02)
Expected move: +/- 13.49%
4.81% $ 11.56
Live Chart Being Loaded With Signals
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States...
Stats | |
---|---|
Volumen de hoy | 788 942 |
Volumen promedio | 1.27M |
Capitalización de mercado | 602.48M |
EPS | $0 ( 2024-03-25 ) |
Próxima fecha de ganancias | ( $-0.610 ) 2024-06-05 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -4.86 |
ATR14 | $0.0370 (0.32%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-17 | Skorpios Trust | Sell | 3 600 000 | Common Stock |
2024-04-01 | Ticho Barry | Sell | 442 | Stock Option (Right to Buy) |
2024-04-01 | Ticho Barry | Buy | 442 | Common Stock |
2024-04-01 | Ticho Barry | Sell | 9 426 | Common Stock |
2024-04-01 | Nash Huw M. | Sell | 50 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
-65.73 |
Last 99 transactions |
Buy: 2 052 338 | Sell: 5 167 636 |
Volumen Correlación
Stoke Therapeutics Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
RMRM | 0.897 |
KINS | 0.882 |
NXTC | 0.865 |
NRBO | 0.861 |
AGLE | 0.858 |
TLGT | 0.857 |
SVOK | 0.857 |
BRQS | 0.853 |
AVCT | 0.853 |
PAIC | 0.853 |
10 Correlaciones Más Negativas | |
---|---|
NRIM | -0.926 |
AMRB | -0.896 |
UFPT | -0.888 |
NETE | -0.887 |
VCYT | -0.886 |
MMAC | -0.885 |
PSL | -0.882 |
MMSI | -0.88 |
PODD | -0.879 |
SFM | -0.878 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Stoke Therapeutics Inc Correlación - Moneda/Commodity
Stoke Therapeutics Inc Finanzas
Annual | 2023 |
Ingresos: | $8.78M |
Beneficio Bruto: | $4.05M (46.14 %) |
EPS: | $-2.38 |
FY | 2023 |
Ingresos: | $8.78M |
Beneficio Bruto: | $4.05M (46.14 %) |
EPS: | $-2.38 |
FY | 2022 |
Ingresos: | $12.41M |
Beneficio Bruto: | $8.87M (71.50 %) |
EPS: | $-2.39 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-2.33 |
Financial Reports:
No articles found.
Stoke Therapeutics Inc
Stoke Therapeutics, Inc., an early-stage biopharmaceutical company, develops novel antisense oligonucleotide (ASO) medicines to treat the underlying causes of severe genetic diseases in the United States. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output to design ASOs to precisely upregulate protein expression. Its lead clinical candidate is STK-001, which is in phase I/IIa clinical trial to treat Dravet syndrome, a severe and progressive genetic epilepsy; and STK-002, which is in preclinical stage for the treatment of autosomal dominant optic atrophy. It had entered into a license and collaboration agreement with Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of severe and rare genetic neurodevelopmental diseases of the central nervous system. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico